{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:04:08Z","timestamp":1768993448554,"version":"3.49.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.amjopharm.2009.10.001","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T09:36:41Z","timestamp":1259401001000},"page":"233-249","source":"Crossref","is-referenced-by-count":57,"title":["A review of heart failure management in the elderly population"],"prefix":"10.1016","volume":"7","author":[{"given":"Judy W.M.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Nayar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2009.10.001_bib1","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib2","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/CIRCULATIONAHA.108.191261","article-title":"Heart disease and stroke statistics\u20142009 update: A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [published correction appears in Circulation. 2009;119:e182]","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjopharm.2009.10.001_bib4","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure [published correction appears in JAMA. 1995;274:462]","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2009.10.001_bib5","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1053\/euhj.2000.2311","article-title":"Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial","volume":"21","author":"Ryd\u00e9n","year":"2000","journal-title":"Eur Heart J."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/0735-1097(89)90294-5","article-title":"Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure","volume":"13","author":"Giles","year":"1989","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting enzyme inhibitors: The CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib8","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of angiotensinreceptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib12","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib13","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2009.10.001_bib14","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.90.4.1765","article-title":"A randomized trial of beta-blockade in heart failure","volume":"90","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.amjopharm.2009.10.001_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS- II): A randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2009.10.001_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carve- dilol Or Metoprolol European Trial (COMET): Randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.amjcard.2004.11.052","article-title":"Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials","volume":"95","author":"Dulin","year":"2005","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/eurheartj\/ehi735","article-title":"Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: Results of the SENIORS echocardiographic sub-study [published correction appears in Eur Heart J. 2006;27:1760]","volume":"27","author":"Ghio","year":"2006","journal-title":"Eur Heart J."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib20","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [published correction appears in N Engl J Med. 2003;348:2271]","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib22","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0735-1097(02)01708-4","article-title":"Clinical benefits of low serum digoxin concentrations in heart failure","volume":"39","author":"Adams","year":"2002","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","article-title":"Association of serum digoxin concentration and outcomes in patients with heart failure","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2009.10.001_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199307013290101","article-title":"Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors","volume":"329","author":"Packer","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2009.10.001_bib25","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study","volume":"314","author":"Cohn","year":"1986","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib27","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure [published correction appears N Engl J Med. 2005;352:1276]","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1071-9164(99)90001-5","article-title":"Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trials","volume":"5","author":"Carson","year":"1999","journal-title":"J Card Fail."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib30","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib31","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00002512-199914030-00001","article-title":"Drugs, heart failure and quality of life: What are we achieving? What should we be trying to achieve?","volume":"14","author":"Doba","year":"1999","journal-title":"Drugs Aging."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/eurheartj\/ehn539","article-title":"Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II","volume":"30","author":"Komajda","year":"2009","journal-title":"Eur Heart J."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib34","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/01.CIR.97.22.2202","article-title":"Indications for ACE inhibitors in the early treatment of myocardial infarction: Systemic overview of individual data from 100,000 patients in randomized trials","volume":"97","year":"1998","journal-title":"Circulation."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/j.1875-9114.1997.tb03681.x","article-title":"Variable furosemide absorption and poor predictability of response in elderly patients","volume":"17","author":"Murray","year":"1997","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2125.1994.tb04273.x","article-title":"The acute effects of a single dopamine infusion in elderly patients with congestive cardiac failure","volume":"37","author":"Robinson","year":"1994","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib37_1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccl.2007.08.010","article-title":"Heart failure in the twenty\u2013first century: Is it a coronary artery disease or hypertension problem?","volume":"25","author":"Velagaleti","year":"2007","journal-title":"Cardiol Clin."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib37_2","doi-asserted-by":"crossref","first-page":"v","DOI":"10.1016\/j.ccl.2007.08.010","article-title":"Heart failure in the twenty\u2013first century: Is it a coronary artery disease or hypertension problem?","volume":"25","author":"Velagaleti","year":"2007","journal-title":"Cardiol Clin."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.CIR.0000048123.22359.A0","article-title":"Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: Implications for systolic and diastolic reserve limitations","volume":"107","author":"Kawaguchi","year":"2003","journal-title":"Circulation."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0002-9149(03)00822-1","article-title":"Mild renal insufficiency and risk of congestive heart failure in men and women \u226570 years of age","volume":"92","author":"Chae","year":"2003","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005)","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib42","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","article-title":"Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure","volume":"42","author":"Braunstein","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.amjmed.2004.12.019","article-title":"Office management of heart failure in the elderly","volume":"118","author":"Rich","year":"2005","journal-title":"Am J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijcard.2007.10.002","article-title":"Diastolic heart failure in the elderly: Underlying mechanisms and clinical relevance","volume":"125","author":"McDonald","year":"2008","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib45","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0002-9149(00)00705-0","article-title":"Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure","volume":"85","author":"Krumholz","year":"2000","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib46","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/01.ASN.0000018409.45834.FA","article-title":"Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study","volume":"13","author":"McClellan","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01498-5","article-title":"The prognostic importance of anemia in patients with heart failure","volume":"114","author":"Kosiborod","year":"2003","journal-title":"Am J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib48","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ahj.2007.10.040","article-title":"Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications","volume":"155","author":"Mascarenhas","year":"2008","journal-title":"Am Heart J."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0735-1097(01)01334-1","article-title":"Depressive symptoms and risk of functional decline and death in patients with heart failure","volume":"38","author":"Vaccarino","year":"2001","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.160.6.777","article-title":"Consumption of NSAIDs and the development of congestive heart failure in elderly patients: An underrecognized public health problem","volume":"160","author":"Page","year":"2000","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib51","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejheart.2006.11.001","article-title":"Cognitive impairment in heart failure: A systematic review of the literature","volume":"9","author":"Vogels","year":"2007","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib52","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1046\/j.1532-5415.2002.50611.x","article-title":"Nutritional status using mini nutritional assessment and subjective global assessment predict mortality in geriatric patients","volume":"50","author":"Persson","year":"2002","journal-title":"J Am Geriatr Soc."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib53","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJM199606063342307","article-title":"Hip fracture","volume":"334","author":"Zuckerman","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib54","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/S0149-2918(03)80196-0","article-title":"Patterns of pharmacologic treatment of congestive heart failure in elderly nursing home residents and related issues: A review of the literature","volume":"25","author":"Litaker","year":"2003","journal-title":"Clin Ther."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib55","series-title":"2009 Physicians' Desk Reference (PDR)","year":"2009"},{"key":"10.1016\/j.amjopharm.2009.10.001_bib56","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-106-3-346","article-title":"Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure","volume":"106","author":"Packer","year":"1987","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib57","first-page":"141","article-title":"High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese","volume":"40","author":"Woo","year":"1995","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib58","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-117-3-234","article-title":"Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology","volume":"117","author":"Israili","year":"1992","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib59","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/archinte.164.8.910","article-title":"Angioedema associated with angiotensin-converting enzyme inhibitor use: Outcome after switching to a different treatment","volume":"164","author":"Cicardi","year":"2004","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib60","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1345\/aph.19294","article-title":"Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema","volume":"34","author":"Warner","year":"2000","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib61_1","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1001\/archinternmed.2008.511","article-title":"Comparative effectiveness of beta-blockers in elderly patients with heart failure","volume":"168","author":"Kramer","year":"2008","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib61_2","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1001\/archinternmed.2008.511","article-title":"Comparative effectiveness of beta-blockers in elderly patients with heart failure","volume":"168","author":"Kramer","year":"2008","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib62","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib63","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/archinte.1994.00420170045004","article-title":"Diuretic treatment for the sodium retention of congestive heart failure","volume":"154","author":"Cody","year":"1994","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib64","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0002-8703(82)90333-7","article-title":"Postural hypotension during tilt with chronic captopril and diuretic therapy for severe congestive heart failure","volume":"103","author":"Cody","year":"1982","journal-title":"Am Heart J."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib65","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/01.CIR.63.3.658","article-title":"Postural hypotension and tachycardia during hydralazine\u2014isosorbide dinitrate therapy for chronic heart failure","volume":"63","author":"Massie","year":"1981","journal-title":"Circulation."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib66","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib67","doi-asserted-by":"crossref","first-page":"21G","DOI":"10.1016\/j.amjcard.2008.06.007","article-title":"Pharmacologic therapies across the continuum of left ventricular dysfunction","volume":"102","author":"Abraham","year":"2008","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib68","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/pgmj.75.883.275","article-title":"Evaluation of renal function in elderly heart failure patients on ACE inhibitors","volume":"75","author":"Jolobe","year":"1999","journal-title":"Postgrad Med J."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib70","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0002-9343(02)01346-3","article-title":"The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure","volume":"113","author":"Sin","year":"2002","journal-title":"Am J Med."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0735-1097(02)02696-7","article-title":"Gender, age, and heart failure with preserved left ventricular systolic function","volume":"41","author":"Masoudi","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib72","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.amjcard.2008.11.047","article-title":"Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction","volume":"103","author":"Tehrani","year":"2009","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.amjopharm.2009.10.001_bib73","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.299.21.2533","article-title":"Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure","volume":"299","author":"Allen","year":"2008","journal-title":"JAMA"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594609000671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594609000671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T21:54:51Z","timestamp":1710712491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594609000671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1543594609000671"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2009.10.001","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}